Alkermes Says Experimental Drug Improved Wakefulness in Narcolepsy Trial
2026-06-17 20:21:28
Alkermes Plc said an experimental drug improved wakefulness and reduced daytime sleepiness in people with a form of narcolepsy. In a statement, according to Bloomberg, the company said the findings suggest a promising new class of medicines could help more patients than originally expected.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
